Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Tuberculosis

Free Subscription Articles published in J Infect Retrieve available abstracts of 57 articles: HTML format

Single Articles

April 2024
1. LIANG Q, Jiang X, Jia J, Zhao L, et al
   An early and trustable indicator suggestive of non-tuberculosis mycobacteria isolation in a high Tuberculosis burden setting.
   J Infect. 2024 Apr 2:106149. doi: 10.1016/j.jinf.2024.106149.
   PubMed     Abstract available
   
   
   February 2024
2. BUREL JG, Wang W, Wuhrer M, Dedicoat M, et al
   IgG glycosylation associates with risk of progression from latent to active tuberculosis.
   J Infect. 2024 Feb 1:S0163-4453(24)00033-1. doi: 10.1016/j.jinf.2024.
   PubMed     Abstract available
   
   
   December 2023
3. LONG R, Croxen M, Lee R, Doroshenko A, et al
   The Association between PHYLOGENETIC LINEAGE AND THE SUBCLINICAL Phenotype OF PULMONARY TUBERCULOSIS: A retrospective 2-Cohort study.
   J Infect. 2023 Dec 15:S0163-4453(23)00592-3. doi: 10.1016/j.jinf.2023.
   PubMed     Abstract available
   
   
   
4. LIU Y, Sun R, Zhang H, Huang J, et al
   Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
   J Infect. 2023;87:e100-e103.
   PubMed    
   
   
   November 2023
5. HUANG Z, Huang H, Hu J, Xia L, et al
   A novel quantitative urine LAM strip for point-of-care tuberculosis diagnosis in non-HIV adults.
   J Infect. 2023 Nov 28:S0163-4453(23)00586-8. doi: 10.1016/j.jinf.2023.
   PubMed    
   
   
   October 2023
6. ZHANG G, Zhang H, Zhang Y, Hu X, et al
   Targeted Next-Generation Sequencing Technology Showed Great Potential in Identifying Spinal Tuberculosis and Predicting the Drug Resistance.
   J Infect. 2023 Oct 26:S0163-4453(23)00549-2. doi: 10.1016/j.jinf.2023.
   PubMed    
   
   
   
7. CHESOV E, Chesov D, Reimann M, Dreyer V, et al
   Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of Moldova.
   J Infect. 2023 Oct 10:S0163-4453(23)00532-7. doi: 10.1016/j.jinf.2023.
   PubMed    
   
   
   September 2023
8. WANG L, Ma H, Wen Z, Niu L, et al
   Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung.
   J Infect. 2023 Sep 8:S0163-4453(23)00506-6. doi: 10.1016/j.jinf.2023.
   PubMed     Abstract available
   
   
   June 2023
9. PEDERSEN OS, Holmgaard FB, Mikkelsen MKD, Lange C, et al
   Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.
   J Infect. 2023 Jun 23:S0163-4453(23)00337-7. doi: 10.1016/j.jinf.2023.
   PubMed     Abstract available
   
   
   April 2023
10. MORRISON H, Perrin F, Dedicoat M, Ahmed R, et al
    Impact of COVID-19 on NHS Tuberculosis Services: Results of a UK-wide survey.
    J Infect. 2023 Apr 10:S0163-4453(23)00204-9. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    March 2023
11. WANG Y, Sun Q, Zhang Y, Li X, et al
    Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas.
    J Infect. 2023 Mar 30:S0163-4453(23)00191-3. doi: 10.1016/j.jinf.2023.
    PubMed     Abstract available
    
    
    
12. NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
    Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
    J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
13. CLARKE J, Moore M, O'Shea MK, Dedicoat M, et al
    Identifying opportunities to improve the microbiological diagnosis of Tuberculosis in a low endemic urban setting.
    J Infect. 2023 Mar 9:S0163-4453(23)00137-8. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    February 2023
14. BIRD PW, Pan D, Martin CA, Gogoi M, et al
    Awareness of HIV, Hepatitis B, Hepatitis C, Tuberculosis and COVID-19 in Migrant Students in the UK - A Pilot Survey from an Institute of Higher Education.
    J Infect. 2023 Feb 14:S0163-4453(23)00086-5. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
15. KOEHLER N, Andres S, Merker M, Dreyer V, et al
    Pretomanid-Resistant Tuberculosis.
    J Infect. 2023 Feb 2:S0163-4453(23)00069-5. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    January 2023
16. NORDHOLM AC, Andersen AB, Wejse C, Norman A, et al
    Mental illness, substance abuse, and tuberculosis risk.
    J Infect. 2023 Jan 27:S0163-4453(23)00056-7. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
17. WU X, Liang R, Xiao Y, Liu H, et al
    Application of Targeted Next Generation Sequencing Technology in the Diagnosis of Mycobacterium Tuberculosis and First Line Drugs Resistance Directly from Cell-free DNA of Bronchoalveolar Lavage Fluid.
    J Infect. 2023 Jan 24:S0163-4453(23)00036-1. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
18. ZHAN H, Yang L, Liu Y, Li H, et al
    Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.
    J Infect. 2023 Jan 21:S0163-4453(23)00034-8. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    December 2022
19. KAUR K, Sharma S, Abhishek S, Kaur P, et al
    Metabolic switching and cell wall remodelling of Mycobacterium tuberculosis during bone tuberculosis.
    J Infect. 2022 Dec 19:S0163-4453(22)00704-6. doi: 10.1016/j.jinf.2022.
    PubMed     Abstract available
    
    
    
20. LI X, Peng K, Cheng FW, Lam DC, et al
    Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).
    J Infect. 2022 Dec 17:S0163-4453(22)00706-X. doi: 10.1016/j.jinf.2022.
    PubMed    
    
    
    
21. XU J, Wang Y, Liu F, Yang H, et al
    Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic.
    J Infect. 2022 Dec 11:S0163-4453(22)00699-5. doi: 10.1016/j.jinf.2022.
    PubMed    
    
    
    November 2022
22. CALDERWOOD CJ, Reeve BW, Mann T, Palmer Z, et al
    Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    J Infect. 2022 Nov 11. pii: S0163-4453(22)00639.
    PubMed     Abstract available
    
    
    
23. HU S, You Y, Zhang S, Tang J, et al
    Multidrug-resistant infection in COVID-19 patients: a meta-analysis.
    J Infect. 2022 Nov 5. pii: S0163-4453(22)00640.
    PubMed    
    
    
    September 2022
24. ZHOU Y, Anthony R, Wang S, Ou X, et al
    Corrigendum to 'The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives' [Journal of Infection, Volume 80, Issue 4 (2020) Pages 444-453].
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00543.
    PubMed    
    
    
    August 2022
25. CHEN YC, Hsiao CC, Wu CC, Chao TY, et al
    Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosis.
    J Infect. 2022 Aug 31. pii: S0163-4453(22)00517.
    PubMed     Abstract available
    
    
    
26. XU Y, Tan Y, Zhang X, Cheng M, et al
    Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.
    J Infect. 2022 Aug 22. pii: S0163-4453(22)00501.
    PubMed     Abstract available
    
    
    
27. LEE DG, Kim HJ, Park MJ, Hong JH, et al
    Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure: Altered protein expression in failed MDR-TB treatment.
    J Infect. 2022 Aug 17. pii: S0163-4453(22)00473.
    PubMed    
    
    
    July 2022
28. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    PubMed    
    
    
    
29. DHANA A, Hamada Y, Kengne AP, Kerkhoff AD, et al
    Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
    J Infect. 2022;85:40-48.
    PubMed     Abstract available
    
    
    June 2022
30. TUNESI S, Du DL, Gualano G, Millet JP, et al
    Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
    J Infect. 2022;84:834-872.
    PubMed    
    
    
    May 2022
31. BACHIR M, Guglielmetti L, Tunesi S, Billard-Pomares T, et al
    Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France.
    J Infect. 2022 May 20. pii: S0163-4453(22)00306.
    PubMed     Abstract available
    
    
    
32. WYLLIE D, Do T, Myers R, Nikolayevskyy V, et al
    M. tuberculosis microvariation is common and is associated with transmission: analysis of three years prospective universal sequencing in England.
    J Infect. 2022 May 17. pii: S0163-4453(22)00294.
    PubMed     Abstract available
    
    
    
33. CHEN Y, Liu Q, Takiff HE, Gao Q, et al
    Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission.
    J Infect. 2022 May 16. pii: S0163-4453(22)00293.
    PubMed     Abstract available
    
    
    April 2022
34. LIU Q, Chen X, Liu X, Yang D, et al
    Cervical lymph node dissection on the treatment of cervical tuberculosis.
    J Infect. 2022 Apr 25. pii: S0163-4453(22)00242.
    PubMed    
    
    
    January 2022
35. LUO Y, Xue Y, Song H, Tang G, et al
    Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00666.
    PubMed     Abstract available
    
    
    
36. LUCEY O, Potter J, Ricketts W, Castle L, et al
    Utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis in East London.
    J Infect. 2022;84:17-23.
    PubMed     Abstract available
    
    
    October 2021
37. MONICA R, Lin NW, Laura D, Fidelma F, et al
    Latent tuberculosis infection amongst patients with rheumatic diseases in an Irish Tertiary Referral Centre - A five-year review.
    J Infect. 2021 Oct 27. pii: S0163-4453(21)00510.
    PubMed    
    
    
    August 2021
38. DAI Y, Xie L, Wang X, Zhang H, et al
    Depression increases the risk of tuberculosis: preliminary observations.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00369.
    PubMed    
    
    
    July 2021
39. CHENDI BH, Tveiten H, Snyders CI, Tonby K, et al
    CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
    J Infect. 2021 Jul 29. pii: S0163-4453(21)00379.
    PubMed     Abstract available
    
    
    
40. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    PubMed     Abstract available
    
    
    
41. TAN Y, Deng Y, Yan X, Liu F, et al
    Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.
    J Infect. 2021;83:46-53.
    PubMed     Abstract available
    
    
    
42. SONG Y, Dong Y, Liao Y, Liang Z, et al
    Apoptotic caspases suppress Mycobacterium bovis-induced IFN-beta production in murine macrophage.
    J Infect. 2021;83:61-68.
    PubMed     Abstract available
    
    
    May 2021
43. DILLARD LK, Martinez RX, Perez LL, Fullerton AM, et al
    Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review: Ototoxic hearing loss in drug-resistant tuberculosis.
    J Infect. 2021 May 17. pii: S0163-4453(21)00252.
    PubMed     Abstract available
    
    
    
44. SAM IK, Chen YY, Ma J, Li SY, et al
    TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.
    J Infect. 2021 May 2. pii: S0163-4453(21)00219.
    PubMed     Abstract available
    
    
    February 2021
45. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.
    PubMed    
    
    
    
46. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    PubMed     Abstract available
    
    
    
47. PATTERSON B, Abbara A, Collin S, Henderson M, et al
    Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    J Infect. 2021;82:240-244.
    PubMed     Abstract available
    
    
    January 2021
48. LOGAN C, Mullender C, Mirfenderesky M, Feasey N, et al
    Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity.
    J Infect. 2021;82:90-97.
    PubMed     Abstract available
    
    
    
49. AHN CS, Shin JW, Kim JG, Lee WY, et al
    Spectrum of pleuropulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years.
    J Infect. 2021;82:150-158.
    PubMed     Abstract available
    
    
    
50. HEAD IM, Lazarus R
    Use of Xpert MTB/RIF in a low prevalence setting in the Southwest of England.
    J Infect. 2021;82:159-198.
    PubMed    
    
    
    December 2020
51. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    PubMed     Abstract available
    
    
    
52. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    PubMed     Abstract available
    
    
    
53. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    PubMed     Abstract available
    
    
    
54. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    PubMed     Abstract available
    
    
    November 2020
55. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    PubMed     Abstract available
    
    
    September 2020
56. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    PubMed     Abstract available
    
    
    August 2020
57. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.